GU Cancers 2020 | Nivo and ipi: long-term F/U in RCC

Elizabeth Plimack, MD, MS, Fox Chase Cancer Center, Philadelphia, PA, outlines her research top picks from the 2020 ASCO GU meeting. Specifically, Dr Plimack highlights updates on two studies investigating nivolumab (nivo) and ipilimumab (ipi) in the treatment of renal cell carcinoma (RCC) . This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.